Use of disease modifying anti-rheumatic drugs and risk of multiple myeloma in US Veterans with rheumatoid arthritis

Use of disease modifying anti-rheumatic drugs and risk of multiple myeloma in US Veterans with rheumatoid arthritis

Abstract Background Biologic (b) and targeted synthetic (ts) disease-modifying anti-rheumatic drugs (DMARDs) used in the management of rheumatoid arthritis (RA) target inflammatory pathways implicated in the pathogenesis of multiple myeloma (MM). It is unknown whether use of b/tsDMARDs affects the i...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kate Tokareva, Alexander C. Peterson, Aaron Baraff, Sarah P. Chung, Jennifer Barton, Joshua F. Baker, Bryant R. England, Ted R. Mikuls, Nicholas L. Smith, David G. Coffey, Noel S. Weiss, Namrata Singh
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	BMC Rheumatology
Subjects:	Tumor necrosis factor inhibitors Rheumatoid arthritis Multiple myeloma
Online Access:	https://doi.org/10.1186/s41927-025-00457-3
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Illuminating the Shadows: Innovation in Advanced Imaging Techniques for Myeloma Precursor Conditions
by: Kara I. Cicero, et al.
Published: (2025-01-01)

CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA
by: Ugo Testa, et al.
Published: (2024-10-01)

Unveiling new therapeutic horizons in rheumatoid arthritis: an In-depth exploration of circular RNAs derived from plasma exosomes
by: Guoqing Li, et al.
Published: (2025-01-01)

Chromothripsis in Treatment Resistance in Multiple Myeloma
by: Kyoung Joo Lee, et al.
Published: (2017-09-01)

Is There a Role for Daratumumab Retreatment in Patients with Relapsed/Refractory Multiple Myeloma?
by: Davor Galusic, et al.
Published: (2025-01-01)

High-Titer Rheumatoid Factor is Associated with Worse Clinical Outcomes and Higher Needs for Advanced Therapies in Rheumatoid Arthritis Under Real-Life Conditions
by: Victor Davi R. S. Oliveira, et al.
Published: (2024-12-01)

Differential diagnosis of rheumatic manifestations of acromegaly. Case report
by: Margarita A. Perepelova, et al.
Published: (2024-12-01)

Risk Evaluation for the Formation of Gastroduodenal Erosion and Ulceration Induced by Meloxicam in Patients with Seropositive and Seronegative Rheumatoid Arthritis
by: R. A. Pavlyukov, et al.
Published: (2019-05-01)

Incorporation and Effect of Arachidonic Acid on the Growth of Human Myeloma Cell Lines
by: V. Desplat, et al.
Published: (1999-01-01)

Evaluation of plasma cell sorting methods in multiple myeloma patients: flow cytometry versus magnetic beads
by: Yu Jeong Choi, et al.
Published: (2025-01-01)

Exploring the role of circulating proteins in multiple myeloma risk: a Mendelian randomization study
by: Matthew A. Lee, et al.
Published: (2025-01-01)

Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ/Parkin axis
by: Xuejie Gao, et al.
Published: (2025-01-01)

Prognostic correlation analysis of multiple myeloma based on HALP score of peripheral blood before chemotherapy
by: CHEN Min, et al.
Published: (2025-01-01)

Impact of Likelihood Ratios of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody in Clinical Diagnosis of Rheumatoid Arthritis by Two Available Platforms
by: Juan Irure-Ventura, et al.
Published: (2025-01-01)

Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effects
by: Ada Alice Dona, et al.
Published: (2025-01-01)

Avascular necrosis in pediatric rheumatic diseases: an Italian retrospective multicentre study
by: Ivan Taietti, et al.
Published: (2025-01-01)

From Multimorbidity to Network Medicine in Patients with Rheumatic Diseases
by: Winston Gilcrease, et al.
Published: (2024-11-01)

A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients
by: Vinod Narayan, et al.
Published: (2019-01-01)

Metabolomics approach reveals key plasma biomarkers in multiple myeloma for diagnosis, staging, and prognosis
by: Xiaoxue Wang, et al.
Published: (2025-02-01)

The association between the dietary inflammatory index and multiple myeloma: a case–control study
by: Hoda Zahedi, et al.
Published: (2025-01-01)

Exploring the predictive power of antinuclear antibodies and Rheumatoid factor correlations in anticipating therapeutic outcomes for female patients with coexisting Sjögren's syndrome and Rheumatoid arthritis
by: Anitha Krishnan Pandarathodiyil, et al.
Published: (2025-03-01)

Detection of new single nucleotide polymorphisms in plasma cells carcinoma (myeloma) by polymerase chain reaction–single strand conformation polymorphism and sequencing technical methods
by: Sarah K. Obayes, et al.
Published: (2024-01-01)

Real-world prognostic factors in autotransplanted multiple myeloma patients with severe renal impairment: study of the Polish Myeloma Study Group
by: Anna Waszczuk-Gajda, et al.
Published: (2020-04-01)

High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment
by: Halina Urbanska-Rys, et al.
Published: (2003-01-01)

Knowledge, attitude and practice towards multiple myeloma among medical staff in Enshi Region
by: Luping Zou, et al.
Published: (2025-01-01)

Guillain-Barré syndrome in patients with multiple myeloma: three cases report and literature review
by: Zhichao Li, et al.
Published: (2025-01-01)

Bortezomib, thalidomide, and dexamethasone versus thalidomide and dexamethasone for response rates in multiple myeloma patients: a retrospective study
by: Juan M. Cano-Calderón, et al.
Published: (2025-01-01)

Evaluation of B cell related markers and autoantibodies in rheumatoid arthritis patients treated with abatacept
by: Ting Wang, et al.
Published: (2025-01-01)

Synchronous multiple myeloma and lung adenocarcinoma: A clinical series
by: Fang Ye, et al.
Published: (2024-04-01)

Targeting BCMA in multiple myeloma: designs, challenges, and future directions
by: Yi Hu, et al.
Published: (2025-02-01)

Prognostic signature based on mitochondria- and angiogenesis-related genes associated with immune microenvironment of multiple myeloma
by: Dai Zhang, et al.
Published: (2025-12-01)

The Role of Prolactin as a Disease Activity Indicator in Some Rheumatic Diseases
by: Mohamed Ismail Abdelkarem, et al.
Published: (2025-07-01)

Ultrasonography of articular and periarticular structures as a relapse predictor in patients with clinically remitted rheumatoid arthritis
by: Mehdi Karami, et al.
Published: (2020-01-01)

Introduction to the South African Rheumatism and Arthritis Association 2024 guidelines
by: B Hodkinson, et al.
Published: (2024-09-01)

Detection of early relapse in multiple myeloma patients
by: Tereza Růžičková, et al.
Published: (2025-01-01)

A systematic epidemiological trends analysis study in global burden of multiple myeloma and 29 years forecast
by: Qianru Hou, et al.
Published: (2025-01-01)

Beliefs and outlook toward medications in Indian patients with very early rheumatoid arthritis: Cross sectional survey
by: Sakir Ahmed, et al.
Published: (2020-01-01)

Chemotherapy plus therapeutic plasmapheresis with 4% human albumin solution in multiple myeloma patients with acute kidney injury: a prospective, open-label, proof-of-concept study
by: Tianzhi Wu, et al.
Published: (2024-12-01)

Burden of associated comorbidities in autoimmune rheumatic diseases in Indian population: An interim report based on the Indian rheumatology association database
by: S Chandrashekara, et al.
Published: (2022-01-01)

Pedobarographic Measurements of Rheumatoid Feet Compared with Clinical Parameters
by: Yasemin YUMUSAKHUYLU, et al.
Published: (2022-03-01)